Lantana

Lantana camara leaves contain triterpenoids (ursolic acid, oleanolic acid), flavonoids, iridoid glycosides, and phenolics that exert antimicrobial, anti-inflammatory, and wound-healing effects by modulating enzymes such as COX-2, 5-LOX, and acetylcholinesterase while scavenging free radicals. In Papua New Guinea and other Pacific Island communities, leaf preparations are applied topically to treat skin sores and wounds, supported by in vitro antimicrobial and antioxidant data (DPPH IC50 316.87 ppm in ethanol leaf extract) but with no large-scale human clinical trials confirming efficacy or safety.

Origin & History

Lantana camara is native to the tropical Americas, spanning Central America, South America, and the Caribbean, but has naturalized extensively across Africa, Asia, Australia, and Pacific Island nations including Papua New Guinea, where it is now considered an invasive weed. It thrives in disturbed habitats, roadsides, forest margins, and secondary vegetation at elevations up to 2,000 meters, tolerating a wide range of soil types and climatic conditions. Despite its invasive status, its prolific growth and accessibility have made it a widely exploited ethnomedicinal plant in resource-limited communities throughout the Pacific Islands and tropical developing regions.

Historical & Cultural Context

Lantana camara has been used in traditional medicine across tropical regions of Africa, Asia, and the Pacific Islands for centuries, with documented ethnomedical applications spanning antipyretic, antimicrobial, wound-healing, and anti-inflammatory purposes across dozens of distinct cultural systems. In Papua New Guinea, leaf preparations for treating skin sores represent a well-documented community practice, reflecting broader Pacific Island ethnobotanical traditions where accessible invasive plants are incorporated into local healing practices. In South Asian Ayurvedic and African traditional systems, roots are used to extract oleanolic acid-containing preparations, while flowers and leaves are prepared as decoctions for fever and respiratory complaints. The plant's historical use as an insecticide and ornamental in addition to its medicinal roles illustrates its multifunctional cultural importance, though its invasive ecology has prompted complex relationships between community acceptance and ecological management efforts.

Health Benefits

- **Wound Healing and Sore Treatment**: Leaf extracts applied topically in PNG traditional medicine leverage phenolics and flavonoids to reduce microbial load and oxidative stress at wound sites; in vitro studies confirm broad-spectrum antimicrobial activity against skin-relevant pathogens.
- **Antioxidant Activity**: Methanolic and ethanolic leaf extracts demonstrate free radical scavenging capacity with a DPPH IC50 of 316.87 ppm, attributable to high total phenolic content (563.57–614.79 mg GAE/g dry weight); this activity may reduce oxidative tissue damage.
- **Anti-Inflammatory Effects**: Triterpenes including ursolic acid and oleanolic acid inhibit COX-2, iNOS, and 5-LOX pathways, reducing prostaglandin and leukotriene synthesis; this mechanism underpins traditional use for fever, swelling, and inflammatory skin conditions.
- **Antimicrobial and Antifungal Properties**: GC-MS-identified compounds including loliolide, phytol, and salicylic acid methyl ester disrupt enzyme function in bacterial and fungal pathogens; molecular docking studies implicate MAPK1, PDF, and SUH targets in phytopathogens such as Magnaporthe oryzae and Xanthomonas spp.
- **Antidiabetic Potential**: Specific triterpenoids—urs-12-en-3β-ol-28-oic acid and stearoyl glucoside of ursolic acid—have demonstrated blood glucose-lowering effects in rodent models, with alpha-amylase inhibition proposed as one contributing mechanism.
- **Antipyretic and Analgesic Use**: Traditional use across Pacific Island and African communities for fever reduction aligns with preclinical evidence of iridoid glycosides and flavonoids modulating inflammatory signaling cascades involved in thermoregulation.
- **Anti-Haemorrhoidal Activity**: A preliminary study tested dry aqueous leaf extract capsules (500 mg/kg formulation combined with lactose) in patients with haemorrhoids, representing one of the few human-use reports, though full clinical outcomes and safety data remain unpublished or unavailable.

How It Works

Ursolic acid and oleanolic acid, the dominant triterpenoids in Lantana camara leaves and roots, inhibit pro-inflammatory enzymes COX-2 and 5-LOX, suppressing prostaglandin E2 and leukotriene B4 synthesis, while also inhibiting protein kinase C and xanthine oxidase to reduce cellular oxidative burden. Flavonoids and phenolic acids contribute antioxidant activity through direct hydrogen-atom donation to reactive oxygen species via phenolic hydroxyl groups, with total phenolic content in leaf extracts reaching 563.57–614.79 mg GAE/g dry weight. Iridoid glycosides and alkaloids (present at 1.8% in leaves, 2.9% in flowers by dry weight) modulate acetylcholinesterase and carboxylesterase activity, with potential implications for neurological and metabolic pathways. GC-MS-identified volatile compounds including phytol, loliolide, and salicylic acid methyl ester interact with pathogen-specific enzyme targets (MAPK1, PDF, SUH), providing the molecular basis for observed antimicrobial efficacy in vitro.

Scientific Research

The evidence base for Lantana camara is dominated by in vitro phytochemical screening, GC-MS compositional analyses, and animal studies, with one preliminary human-use report involving anti-haemorrhoidal capsules lacking full published clinical outcomes or sample size data. Antidiabetic effects of isolated triterpenoids have been demonstrated in rat models with measurable blood glucose reduction, but no dose-response curves or human extrapolation data are available. Antimicrobial studies document activity against a range of bacteria and fungi in disk diffusion and broth microdilution assays, with GC-MS-guided molecular docking studies providing mechanistic hypotheses for observed effects against phytopathogens. No large-scale randomized controlled trials, systematic reviews, or meta-analyses have been conducted, and the overall evidence quality is low; findings should be interpreted as hypothesis-generating rather than clinically conclusive.

Clinical Summary

Human clinical evidence for Lantana camara is extremely limited, with only one identified study using a dry aqueous leaf extract capsule formulation (500 mg/kg with lactose) in haemorrhoid patients, for which detailed outcomes, effect sizes, and sample sizes are not publicly accessible. No randomized controlled trials with defined endpoints, blinding, or statistical power calculations have been published for any therapeutic indication including wound healing, diabetes, or infection. The majority of mechanistic and efficacy data derives from in vitro cell and enzyme assays and small rodent experiments, which cannot be directly translated to human dosing or clinical benefit. Confidence in clinical application remains very low, and the plant's use in PNG and Pacific Island communities represents ethnomedical practice preceding formal clinical validation.

Nutritional Profile

Lantana camara leaves are not consumed as a food source and have no established macronutrient or micronutrient nutritional profile relevant to dietary supplementation. Phytochemically, leaves contain total phenolics at 563.57–614.79 mg gallic acid equivalents per gram dry weight (higher in flowers), total alkaloids at approximately 1.8% dry weight, flavonoids, tannins, saponins, steroids, coumarins, and quinones confirmed by qualitative screening. GC-MS analyses have identified 66 specific compounds in leaf and flower extracts including loliolide, eicosapentaenoic acid, salicylic acid methyl ester, and phytol, with the broader phytochemical inventory totaling approximately 168 reported compounds historically, distributed as steroids/triterpenoids (75.6%), flavonoids (14.3%), fatty acids/miscellaneous (8.9%), and iridoid glucosides (1.2%). Bioavailability of these compounds in humans is entirely unstudied, and the presence of alkaloids and other potentially toxic constituents raises concerns about oral bioavailability investigations in the absence of safety data.

Preparation & Dosage

- **Traditional Leaf Poultice (Topical)**: Fresh leaves are crushed or mashed and applied directly to skin sores, wounds, or inflammatory lesions; no standardized weight or duration established.
- **Macerated Leaf Extract (Research Preparation)**: Powdered leaves macerated in ethanol or methanol at a 1:10–1:20 (w/v) ratio for 24–72 hours at room temperature, filtered, and concentrated; used in laboratory studies but not standardized for human consumption.
- **Dry Aqueous Leaf Extract Capsules (Preliminary Human Use)**: One reported formulation combined 500 mg/kg dry aqueous extract with 100 mg/kg lactose in capsule form for haemorrhoid treatment; this dose is unscaled for routine human use and should not be self-administered.
- **Decoction (Ethnobotanical)**: Leaves, roots, or flowers boiled in water for 10–20 minutes and used as a wash or consumed as a tea in various traditional systems; concentration highly variable.
- **Standardization**: No pharmacopoeial or commercial standardization exists for Lantana camara extracts; no established effective dose range from clinical trials is available for any indication.

Synergy & Pairings

In traditional practice, Lantana camara leaves are occasionally combined with other wound-healing plants rich in tannins or saponins, which may enhance astringent and antimicrobial effects through complementary mechanisms of microbial membrane disruption and protein precipitation. Ursolic acid, the primary triterpenoid, is known from other botanical contexts to exhibit enhanced anti-inflammatory synergy when combined with quercetin or other flavonoids via convergent inhibition of the NF-κB pathway and COX-2 enzyme, a combination potentially relevant to Lantana's own flavonoid co-occurrence. No formal synergy studies have been conducted specifically for Lantana camara extracts in combination with other supplements or pharmaceutical agents.

Safety & Interactions

Lantana camara is well-documented as a toxic plant in veterinary literature, causing lantana poisoning in livestock (cattle, sheep, goats) characterized by hepatotoxicity, photosensitization, and gastrointestinal disturbance attributed to pentacyclic triterpenoid acids and icterogenin; human toxicity risk from oral consumption exists but is not quantified in published clinical literature. No formal drug interaction studies have been conducted in humans, though the plant's inhibition of CYP-related enzymes, COX-2, and acetylcholinesterase suggests potential interactions with NSAIDs, anticoagulants, anticholinergic medications, and antidiabetic drugs. The plant is contraindicated for internal use during pregnancy and lactation given the absence of safety data and known animal toxicity; topical use on broken skin should be approached with caution due to phototoxic potential. No maximum safe dose has been established for human use, and the significant variability in bioactive compound concentrations across geographic populations, plant parts, and extraction methods makes standardized safety assessment currently impossible.